fowlpox virus vaccine
Vaccineexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 1996 (NCT00019175)
Timeline
Indications
Mechanism of action
- OrthopoxvirusImmunity, active
Orthopoxvirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fowlpox virus vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00019669 | Phase 2 | Oct 1, 1999 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
| NCT00003871 | Phase 2 | Aug 1, 1999 | Eastern Cooperative Oncology Group, National Cancer Institute (NCI), Yeshiva University |
| NCT00019734 | Phase 2 | Jul 1, 1999 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
| NCT00019175 | Phase 1 | Aug 1, 1996 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 4 | 3 | 2 | 1996 |
| National Institutes of Health (NIH) | Government | 3 | 0 | 2 | 1996 |
| Eastern Cooperative Oncology Group | Academic/Hospital | 1 | 1 | 1 | 1999 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 1999 |
4 organizations
Page 1 / 1